Sign in to view content

Treatment Response to Antioxidant Supplementation Based on CFH and ARMS2Â Genetic Risk Allele Number in AREDS Patients With No AMD at Baseline

Carl C. Awh, MD, FASRS

Video
Published 2016

Related

Randomized, Prospective Study of Aflibercept for Visually Significant Radiation Maculopathy - Interim Analysis
Timothy G. Murray, MD, MBA, FASRS
Annual Meeting Talks
2016
Computer-Based Image Analysis in Retinopathy of Prematurity: Are We There Yet?
J. Peter Campbell, MD, MPH
Annual Meeting Talks
2016
Differences in Surgical Performance in Peeling the ILM for Macular Holes Between Fellows-in-Training and Experienced Vitreoretinal Surgeons
Robert Gizicki, MD, FRCSC, DABO
Annual Meeting Talks
2016

Category: AMD-Non-Neovascular

See more